ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

SYRE Spyre Therapeutics Inc

33.67
-0.94 (-2.72%)
07 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Spyre Therapeutics Inc SYRE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.94 -2.72% 33.67 16:51:37
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
34.09 33.09 35.79 33.67 34.61
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/6/202416:23PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
30/5/202415:33EDGAR2Form 8-K - Current report
29/5/202407:30PRNUSSpyre Therapeutics to Participate in the Jefferies Global..
16/5/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202415:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/5/202406:40EDGAR2Form 8-K - Current report
15/5/202406:30PRNUSSpyre Therapeutics Appoints Accomplished Biopharma Leader..
09/5/202415:11EDGAR2Form 8-K - Current report
09/5/202415:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202415:02PRNUSSpyre Therapeutics Reports First Quarter 2024 Financial..
03/5/202416:00PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
01/4/202416:00PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
18/3/202407:00PRNUSSpyre Therapeutics Announces $180 Million Private Placement
05/3/202416:15EDGAR2Form POS AM - Post-Effective amendments for registration..
01/3/202416:25PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
01/3/202405:14EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
29/2/202416:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202415:14EDGAR2Form 8-K - Current report
29/2/202415:05PRNUSSpyre Therapeutics Reports Fourth Quarter and Full Year 2023..
26/2/202406:30PRNUSSpyre Therapeutics to Participate in the 44th Annual TD..
20/2/202420:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202414:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202407:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202417:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202406:30PRNUSSpyre Therapeutics Announces Three Abstracts Accepted for..
05/2/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202416:25EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/2/202406:36EDGAR2Form 8-K - Current report
05/2/202406:30PRNUSSpyre Therapeutics Appoints Accomplished Biopharma and IBD..
02/2/202419:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202419:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202419:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202416:30PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
18/1/202415:26EDGAR2Form 8-K - Current report
29/12/202316:00EDGAR2Form SC 13D/A - General statement of acquisition of..
29/12/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202320:56EDGAR2Form D - Notice of Exempt Offering of Securities
22/12/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202316:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/12/202316:00PRNUSSpyre Therapeutics Announces Grants of Inducement Awards
22/12/202315:32EDGAR2Form S-1 - General form for registration of securities under..
11/12/202316:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202316:21EDGAR2Form SC 13D/A - General statement of acquisition of..